Erdafitinib for locally advanced or metastatic urothelial carcinoma

Arlene O. Siefker-Radtke, Yohann Loriot

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)824-825
Number of pages2
JournalAmerican Journal of Health-System Pharmacy
Volume79
Issue number11
DOIs
Publication statusPublished - 1 Jun 2022
Externally publishedYes

Keywords

  • FGFR alteration
  • efficacy
  • erdafitinib
  • safety
  • urothelial carcinoma

Cite this